Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−4.24 USD
−479.45 M USD
563.95 M USD
117.85 M
About Guardant Health, Inc.
Sector
Industry
Headquarters
Palo Alto
Website
Founded
2011
FIGI
BBG006D97VY9
Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2011 and is headquartered in Palo Alto, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where GH is featured.
Frequently Asked Questions
The current price of GH is 34.84 USD — it has decreased by −2.19% in the past 24 hours. Watch Guardant Health, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Guardant Health, Inc. stocks are traded under the ticker GH.
GH stock has fallen by −3.89% compared to the previous week, the month change is a 13.93% rise, over the last year Guardant Health, Inc. has showed a 23.85% increase.
We've gathered analysts' opinions on Guardant Health, Inc. future price: according to them, GH price has a max estimate of 60.00 USD and a min estimate of 19.00 USD. Watch GH chart and read a more detailed Guardant Health, Inc. stock forecast: see what analysts think of Guardant Health, Inc. and suggest that you do with its stocks.
GH stock is 3.68% volatile and has beta coefficient of 1.95. Track Guardant Health, Inc. stock price on the chart and check out the list of the most volatile stocks — is Guardant Health, Inc. there?
Today Guardant Health, Inc. has the market capitalization of 4.40 B, it has decreased by −3.91% over the last week.
Yes, you can track Guardant Health, Inc. financials in yearly and quarterly reports right on TradingView.
Guardant Health, Inc. is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
GH earnings for the last quarter are −0.88 USD per share, whereas the estimation was −0.73 USD resulting in a −20.48% surprise. The estimated earnings for the next quarter are −0.78 USD per share. See more details about Guardant Health, Inc. earnings.
Guardant Health, Inc. revenue for the last quarter amounts to 191.48 M USD, despite the estimated figure of 170.49 M USD. In the next quarter, revenue is expected to reach 186.78 M USD.
GH net income for the last quarter is −107.75 M USD, while the quarter before that showed −102.63 M USD of net income which accounts for −4.99% change. Track more Guardant Health, Inc. financial stats to get the full picture.
No, GH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 18, 2024, the company has 1.78 K employees. See our rating of the largest employees — is Guardant Health, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Guardant Health, Inc. EBITDA is −471.93 M USD, and current EBITDA margin is −92.14%. See more stats in Guardant Health, Inc. financial statements.
Like other stocks, GH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Guardant Health, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Guardant Health, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Guardant Health, Inc. stock shows the buy signal. See more of Guardant Health, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.